Back to results
US 2008/0167302 A1Published application
Peptide Deformylase Inhibitors
AssigneeSmithKlineBeecham Corporation
InventorsKelly M. Aubart, Andrew B. Benowitz, Siegfried B. Christensen IV, Jinhwa Lee, Domingos J. Silva
Life of this patent
Estimating the term…
Abstract
Novel PDF inhibitors and novel methods for their use are provided.
Claims5
A compound according to Formula (1):
- wherein:
- Y represents —C(O)— or a covalent bond;
- R represents a substituted arylene, a substituted heteroarylene or a covalent bond;
- Z represents —CH2—, —NR3—, —O—, —C(O)NR3—, —NR3C(O)— or —CH═CH— when R is a substituted arylene or a substituted heteroarylene, and represents —CH2— or —CH═CH— when R is a covalent bond;
- R3 is hydrogen, C1-3 substituted alkyl, and (CH2)0-2—C3-6 substituted carbocycle;
- R1 is selected from the group consisting of:
- hydrogen, C1-3 substituted alkyl, C2-3 substituted alkenyl, C2-3 substituted alkynyl, and (CH2)0-2—C3-6 substituted carbocycle;
- m is equal to 0 when Z=—NR3— or —CH2—;
- or m is equal to 0 or 1 when Z=—O—, —C(O)NR3— or —NR3C(O)—;
- or m is is an integer between 0 and 6 when Z=—CH═CH—;
- n is an integer equal to or greater than 2, appropriately chosen so that the number of atoms in the macrocyclic ring ranges from 13 to 16;
- or a salt, solvate, or physiologically functional derivative thereof.
9 more elements
Dependencies are inferred from the claim text.